The closing price of Genius Sports Limited (NYSE: GENI) was $10.32 for the day, down -3.01% from the previous closing price of $10.64. In other words, the price has decreased by -$3.01 from its previous closing price. On the day, 2.77 million shares were traded. GENI stock price reached its highest trading level at $10.685 during the session, while it also had its lowest trading level at $10.28.
Ratios:
Our analysis of GENI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 68.62. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on July 25, 2025, initiated with a Outperform rating and assigned the stock a target price of $14.
On July 09, 2025, Arete started tracking the stock assigning a Buy rating and target price of $15.
On July 01, 2025, Truist started tracking the stock assigning a Buy rating and target price of $14.Truist initiated its Buy rating on July 01, 2025, with a $14 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 13 ’25 when Burns Daniel Paul bought 8,157 shares for $10.45 per share.
Stevens Eric bought 79,373 shares of GENI for $744,519 on Mar 06 ’25. On Jan 17 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 100,388 shares for $8.74 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2444560128 and an Enterprise Value of 2233947392. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.90 while its Price-to-Book (P/B) ratio in mrq is 3.81. Its current Enterprise Value per Revenue stands at 4.174 whereas that against EBITDA is -76.929.
Stock Price History:
The Beta on a monthly basis for GENI is 1.86, which has changed by 0.55187964 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $11.74, while it has fallen to a 52-week low of $5.76. The 50-Day Moving Average of the stock is 2.21%, while the 200-Day Moving Average is calculated to be 10.17%.
Shares Statistics:
GENI traded an average of 4.95M shares per day over the past three months and 4420020 shares per day over the past ten days. A total of 239.82M shares are outstanding, with a floating share count of 215.34M. Insiders hold about 10.20% of the company’s shares, while institutions hold 86.93% stake in the company. Shares short for GENI as of 1752537600 were 28984049 with a Short Ratio of 5.86, compared to 1749772800 on 16392491. Therefore, it implies a Short% of Shares Outstanding of 28984049 and a Short% of Float of 13.389999999999999.
Earnings Estimates
A detailed examination of Genius Sports Limited (GENI) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.03, with high estimates of $0.05 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.23 and $0.23 for the fiscal current year, implying an average EPS of $0.23. EPS for the following year is $0.26, with 2.0 analysts recommending between $0.36 and $0.17.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 16 analysts. It ranges from a high estimate of $119.8M to a low estimate of $115.17M. As of the current estimate, Genius Sports Limited’s year-ago sales were $95.45MFor the next quarter, 16 analysts are estimating revenue of $143.77M. There is a high estimate of $145.1M for the next quarter, whereas the lowest estimate is $140.8M.
A total of 17 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $626.3M, while the lowest revenue estimate was $618.3M, resulting in an average revenue estimate of $620.64M. In the same quarter a year ago, actual revenue was $510.89MBased on 16 analysts’ estimates, the company’s revenue will be $720.15M in the next fiscal year. The high estimate is $739.3M and the low estimate is $695.9M.
